4D Molecular Therapeutics (FDMT) Institutional Ownership $6.18 -0.28 (-4.33%) Closing price 04:00 PM EasternExtended Trading$6.29 +0.11 (+1.78%) As of 05:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for 4D Molecular Therapeutics (NASDAQ:FDMT)CurrentInstitutional OwnershipPercentage99.27%Number ofInstitutional Buyers(last 12 months)78TotalInstitutional Inflows(last 12 months)$74.89MNumber ofInstitutional Sellers(last 12 months)45TotalInstitutional Outflows(last 12 months)$103.60M Get FDMT Insider Trade Alerts Want to know when executives and insiders are buying or selling 4D Molecular Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data FDMT Institutional Buying and Selling by Quarter 4D Molecular Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Rangeley Capital LLC13,000$48K0.1%N/A0.028% 8/15/2025 Man Group plc134,932$501K0.0%+159.7%0.289% 8/15/2025 Engineers Gate Manager LP24,015$89K0.0%-67.3%0.051% 8/15/2025 BNP Paribas Financial Markets63,914$237K0.0%+128.5%0.137% 8/15/2025 Bridgeway Capital Management LLC25,000$93K0.0%+100.3%0.054% 8/15/2025 BVF Inc. IL4,629,289$17.18M0.6%+1.5%9.913% 8/14/2025 PDT Partners LLC20,097$75K0.0%-63.5%0.043% 8/14/2025 Jane Street Group LLC190,373$706K0.0%+35.1%0.411% 8/14/2025 Raymond James Financial Inc.455,470$1.69M0.0%+54.7%0.983% 8/14/2025 Redmile Group LLC112,168$416K0.0%-88.8%0.242% Get the Latest News and Ratings for FDMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.21,958$81K0.0%-17.0%0.047% 8/14/2025 The Manufacturers Life Insurance Company 14,849$55K0.0%-20.1%0.032% 8/14/2025 Sei Investments Co.28,535$106K0.0%N/A0.062% 8/14/2025 Federated Hermes Inc.1,667,338$6.19M0.0%+33.4%3.599% 8/13/2025 Marshall Wace LLP257,620$956K0.0%+62.8%0.556% 8/13/2025 Decheng Capital LLC239,510$889K0.2%-28.6%0.517% 8/13/2025 Invesco Ltd.140,325$521K0.0%+19.2%0.303% 8/13/2025 Norges Bank54,219$201K0.0%N/A0.117% 8/13/2025 Quadrature Capital Ltd11,257$42K0.0%N/A0.024% 8/13/2025 Russell Investments Group Ltd.21,816$81K0.0%+11.7%0.047% 8/12/2025 XTX Topco Ltd78,580$292K0.0%N/A0.170% 8/12/2025 American Century Companies Inc.48,810$181K0.0%+11.5%0.105% 8/12/2025 Rhumbline Advisers65,958$245K0.0%-6.8%0.142% 8/12/2025 Dynamic Technology Lab Private Ltd16,369$61K0.0%+35.6%0.035% 8/8/2025 Intech Investment Management LLC20,097$75K0.0%-48.8%0.043% 8/8/2025 Geode Capital Management LLC918,533$3.41M0.0%-4.6%1.983% 8/7/2025 Los Angeles Capital Management LLC11,280$42K0.0%N/A0.024% 7/31/2025 Peapod Lane Capital LLC318,537$1.18M1.2%+62.6%0.688% 7/30/2025 Privium Fund Management B.V.197,458$733K0.2%+50.7%0.426% 7/9/2025 Harbor Capital Advisors Inc.25,211$94K0.0%-17.6%0.054% 7/1/2025 Kera Capital Partners Inc.24,068$89K0.0%N/A0.052% 5/21/2025 Acadian Asset Management LLC400,606$1.29M0.0%+1,103.4%0.865% 5/19/2025 Jane Street Group LLC140,879$455K0.0%-33.2%0.304% 5/16/2025 Goldman Sachs Group Inc.4,168,394$13.46M0.0%-2.5%8.997% 5/16/2025 Dynamic Technology Lab Private Ltd12,074$39K0.0%N/A0.026% 5/16/2025 Millennium Management LLC1,633,987$5.28M0.0%+15.0%3.527% 5/16/2025 BVF Inc. IL4,561,289$14.73M0.6%+70.8%9.846% 5/16/2025 AQR Capital Management LLC14,340$46K0.0%N/A0.031% 5/15/2025 Redmile Group LLC997,235$3.22M0.3%-16.7%2.153% 5/15/2025 PDT Partners LLC54,999$178K0.0%-9.7%0.119% Capital Gains Tax Strategies for Seniors (Ad)Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure. SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation.Click here to see the three strategies and get matched with a financial advisor today.5/15/2025 Cubist Systematic Strategies LLC84,172$272K0.0%-81.2%0.182% 5/14/2025 MetLife Investment Management LLC28,745$93K0.0%-18.8%0.062% 5/14/2025 Hsbc Holdings PLC52,171$166K0.0%+51.6%0.113% 5/14/2025 Wellington Management Group LLP247,471$799K0.0%+39.6%0.534% 5/13/2025 American Century Companies Inc.43,784$141K0.0%+12.9%0.095% 5/13/2025 Russell Investments Group Ltd.19,532$63K0.0%N/A0.042% 5/12/2025 Nuveen LLC150,314$486K0.0%N/A0.324% 5/12/2025 Invesco Ltd.117,768$380K0.0%+318.3%0.254% 5/9/2025 Deutsche Bank AG236,157$763K0.0%-2.4%0.510% 5/9/2025 Charles Schwab Investment Management Inc.282,781$913K0.0%-8.4%0.610% 5/9/2025 Privium Fund Management B.V.131,000$423K0.1%+8.3%0.283% 5/8/2025 Decheng Capital LLC335,515$1.08M0.3%-16.1%0.724% 5/8/2025 Federated Hermes Inc.1,250,181$4.04M0.0%+33,131.8%2.699% 5/6/2025 Proficio Capital Partners LLC25,195$75K0.0%+26.0%0.054% 5/6/2025 Y Intercept Hong Kong Ltd12,627$41K0.0%N/A0.027% 4/30/2025 Alps Advisors Inc.32,811$106K0.0%-12.2%0.071% 4/30/2025 Peapod Lane Capital LLC195,853$633K0.7%+35.3%0.423% 4/29/2025 Bank of New York Mellon Corp134,849$436K0.0%-7.6%0.291% 4/14/2025 Harbor Capital Advisors Inc.30,595$99K0.0%N/A0.066% 3/24/2025 Wellington Management Group LLP177,279$987K0.0%+6.7%0.383% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC44,324$247K0.0%+7.1%0.096% 2/17/2025 Voloridge Investment Management LLC183,899$1.02M0.0%-36.6%0.398% 2/17/2025 VR Adviser LLC2,952,371$16.45M1.1%-32.9%6.386% 2/17/2025 Velan Capital Investment Management LP10,000$56K0.0%N/A0.022% 2/17/2025 Two Sigma Advisers LP126,400$704K0.0%+452.0%0.273% 2/17/2025 Two Sigma Investments LP313,993$1.75M0.0%+196.3%0.679% 2/17/2025 Redmile Group LLC1,196,910$6.67M0.5%-5.2%2.589% 2/17/2025 Point72 Asia Singapore Pte. Ltd.9,025$50K0.0%N/A0.020% 2/17/2025 ProShare Advisors LLC16,369$91K0.0%+30.1%0.035% 2/17/2025 Millennium Management LLC1,420,723$7.91M0.0%+1,607.1%3.073% 2/17/2025 Janus Henderson Group PLC2,252,240$12.54M0.0%-28.2%4.872% 2/17/2025 D. E. Shaw & Co. Inc.36,033$201K0.0%-8.0%0.078% 2/17/2025 Deutsche Bank AG241,853$1.35M0.0%-69.9%0.523% 2/17/2025 Deep Track Capital LP609,900$3.40M0.1%-85.1%1.319% 2/17/2025 Corton Capital Inc.32,722$182K0.1%N/A0.071% 2/17/2025 Cubist Systematic Strategies LLC448,831$2.50M0.0%+2,084.5%0.971% 2/17/2025 BVF Inc. IL2,670,642$14.88M0.5%-63.8%5.777% 2/17/2025 Bank of America Corp DE384,880$2.14M0.0%+49.8%0.833% 2/17/2025 BNP Paribas Financial Markets95,424$532K0.0%N/A0.206% 2/17/2025 Algert Global LLC176,778$985K0.0%+140.7%0.382% 2/17/2025 ArrowMark Colorado Holdings LLC794,598$4.43M0.1%-1.1%1.719% 2/14/2025 RA Capital Management L.P.4,563,211$25.42M0.3%-10.5%9.871% 2/14/2025 Jane Street Group LLC210,824$1.17M0.0%+143.7%0.456% 2/14/2025 PDT Partners LLC60,915$339K0.0%N/A0.132% 2/14/2025 Northern Trust Corp440,665$2.46M0.0%+2.3%0.953% 2/14/2025 Decheng Capital LLC400,000$2.23M0.5%+0.5%0.865% 2/14/2025 Virtus ETF Advisers LLC10,333$58K0.0%+173.9%0.022% 2/14/2025 Nebula Research & Development LLC23,064$128K0.0%+37.4%0.050% 2/14/2025 Price T Rowe Associates Inc. MD26,546$148K0.0%-13.1%0.057% 2/14/2025 Hsbc Holdings PLC34,413$190K0.0%+88.3%0.074% Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.Click here to see why Tesla's about to prove everyone wrong... again.2/14/2025 Tower Research Capital LLC TRC50,253$280K0.0%+282.1%0.109% 2/14/2025 MetLife Investment Management LLC35,395$197K0.0%+21.7%0.077% 2/14/2025 Dimensional Fund Advisors LP131,965$735K0.0%-36.8%0.285% 2/13/2025 Marshall Wace LLP52,744$294K0.0%-68.1%0.114% 2/13/2025 Jump Financial LLC94,689$527K0.0%+25.4%0.205% 2/13/2025 XTX Topco Ltd36,939$206K0.0%N/A0.080% 2/13/2025 Barclays PLC105,245$586K0.0%-8.4%0.228% 2/13/2025 Zuckerman Investment Group LLC20,000$119K0.0%N/A0.043% 2/13/2025 Raymond James Financial Inc.112,904$629K0.0%N/A0.244% 2/13/2025 Bank of Montreal Can21,982$122K0.0%-58.9%0.048% (Data available from 1/1/2016 forward) FDMT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of FDMT shares? During the previous two years, 140 institutional investors and hedge funds held shares of 4D Molecular Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($25.42M), State Street Corp ($22.88M), BVF Inc. IL ($17.18M), VR Adviser LLC ($16.45M), Novo Holdings A S ($16.22M), Vanguard Group Inc. ($15.93M), and Goldman Sachs Group Inc. ($13.46M).Learn more on 4D Molecular Therapeutics' institutional investors. What percentage of 4D Molecular Therapeutics' stock is owned by institutional investors? 99.27% of 4D Molecular Therapeutics' stock is owned by institutional investors. Learn more on FDMT's institutional investor holdings. Which institutional investors have been buying 4D Molecular Therapeutics' stock? Of the 116 institutional investors that purchased 4D Molecular Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($1.98M), BVF Inc. IL ($1.96M), Federated Hermes Inc. ($1.66M), Millennium Management LLC ($1.55M), Assenagon Asset Management S.A. ($1.54M), Redmile Group LLC ($1.45M), and Braidwell LP ($855.99K). How much institutional buying is happening at 4D Molecular Therapeutics? Institutional investors have bought a total of 12,917,330 shares in the last 24 months. This purchase volume represents approximately $74.89M in transactions. Which of 4D Molecular Therapeutics' major shareholders have been selling company stock? Of the 45 institutional investors that sold 4D Molecular Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: BVF Inc. IL ($4.71M), Deep Track Capital LP ($3.49M), VR Adviser LLC ($1.45M), Redmile Group LLC ($1.15M), FMR LLC ($1.01M), Janus Henderson Group PLC ($944.52K), and Assenagon Asset Management S.A. ($889.88K). How much institutional selling is happening at 4D Molecular Therapeutics? Institutional investors have sold a total of 17,247,286 shares in the last 24 months. This volume of shares sold represents approximately $103.60M in transactions. Related Companies SNDX Major Shareholders COGT Major Shareholders EVO Major Shareholders AVDL Major Shareholders PAHC Major Shareholders XERS Major Shareholders CVAC Major Shareholders ELVN Major Shareholders CALT Major Shareholders COLL Major Shareholders This page (NASDAQ:FDMT) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4D Molecular Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 4D Molecular Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access